Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA

Journal of the American Academy of Dermatology

Volumn 35, Issue 5 I, 1996, Pages 685-689

  Hannuksela, Anna ^a   Pukkala, Eero ^b   Hannuksela, Matti ^a   Karvonen, Jaakko ^a  

^a UNIVERSITY OF OULU   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TRIOXYSALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FINLAND; HUMAN; KIDNEY CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; SKIN CANCER; TOPICAL DRUG ADMINISTRATION;

EID: 0029959570     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90721-5     Document Type: Article

References (26)

1. Fischer T, Alsins J. Treatment of psoriasis with trioxsalen baths and dysprosium lamps. Acta Derm Venereol (Stockh) 1976;56:383-90.
2. Hannuksela M, Karvonen J. Topical trioxsalen PUVA therapy. Acta Derm Venereol Suppl(Stockh) 1984;113: 135-8.
3. Turjanmaa K, Salo H, Reunala T. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis. Acta Derm Venereol (Stockh) 1985;65:86-8.
4. Fischer T. Advantages of bath PUVA. Semin Dermatol 1985;4:297-9.
5. Stern RS, Thibodeau LA, Kleinerman RA, et al. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979:300:809-13.
6. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994;73:2759-64.
7. Forman AB, Roenigk HH, Caro WA, et al. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989;125:515-9.
8. Lindelöf B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet 1991; 338:91-3.
9. Chuang T-Y, Heinrich LA, Schultz MD, et al. PUVA and skin cancer. J Am Acad Dermatol 1992;26:173-7.
10. Berne B, Fischer T, Michaelsson G, et al. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients. Photodermatology 1984;1:18-22.
11. Lindelöf B, Sigurgeirsson B, Tegner E, et al. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA: a preliminary report. Arch Dermatol 1992;128:1341-4.
12. Hannuksela M, Stenbäck F, Lahti A. The carcinogenic properties of topical PUVA: a lifelong study in mice. Arch Dermatol Res 1986;278:347-51.
13. Freeman SE, Gange RW, Sutherland JC, et al. Production of pyrimidine dimers in DNA of human skin exposed in situ to UVA radiation. J Invest Dermatol 1987;88:430-3.
14. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway: a questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh) 1989;142:9-12.
15. Mills CM, Srivastava ED, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127:18-21.
16. Poikolainen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994;130:473-7.
17. Lindelöf B, Eklund G, Lidén S, et al. The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 1990;22:1056-60.
18. Kraemer KH, Waters HI, Cohen LF, et al. Effects of 8-Methoxypsoralen and ultraviolet radiation on human lymphoid cells in vitro. J Invest Dermatol 1981;76:80-7.
19. Moscicki RA, Morison WL, Parrish JA, et al. Reduction of the fraction of circulating helper-inducer T cells identified by monoclonal antibodies in psoriatic patients treated with long-term psoralen/ultraviolet-A radiation (PUVA). J Invest Dermatol 1982;79:205-8.
20. Ree K. Reduction of Langerhans cells in human epidermis during PUVA therapy: a morphometric study. J Invest Dermatol 1982;78:488-92.
21. Kripke ML, Morison WL. Modulation of immune system by UV radiation. J Invest Dermatol 1985;85(suppl):62-6s.
22. Jeffes EWB, McCullough JL, Pittelkow MR, et al. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate. J Invest Dermatol 1995;104:183-8.
23. Wong RL, Winslow CM, Cooper KD. The mechanism of action of cyclosporin A in the treatment of psoriasis. Immunol Today 1993;14:69-74.
24. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988;91:197-201.
25. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol 1994;33:365-9.
26. Pukkala E. Use of record linkage in small-area studies. In: Elliot P, Guzick J, English D, et al, editors. Geographical and environmental epidemiology. Oxford: Oxford University Press, 1992;125-31.